دورية أكاديمية

Measurable residual disease (MRD) status before allogeneic hematopoietic cell transplantation impact on secondary acute myeloid leukemia outcome. A Study from the Acute Leukemia Working Party (ALWP) of the European society for Blood and Marrow Transplantation (EBMT)

التفاصيل البيبلوغرافية
العنوان: Measurable residual disease (MRD) status before allogeneic hematopoietic cell transplantation impact on secondary acute myeloid leukemia outcome. A Study from the Acute Leukemia Working Party (ALWP) of the European society for Blood and Marrow Transplantation (EBMT)
المؤلفون: Maffini, EnricoAff1, IDs4140902201748w_cor1, Labopin, Myriam, Beelen, Dietrich Wilhelm, Kroeger, Nicolaus, Arat, Mutlu, Wilson, Keith M. O., Bay, Jacques-Olivier, Ganser, Arnold, Martin, Hans, Passweg, Jakob, Kottaridis, Panagiotis D., Yakoub-Agha, Ibrahim, Porras, Rocio Parody, Wagner, Eva Maria, Esteve, Jordi, Lanza, Francesco, Nagler, ArnonAff2, Aff17, Mohty, MohamadAff2, Aff18
المصدر: Bone Marrow Transplantation: Official journal of the European Society for Blood and Marrow Transplantation. 57(10):1556-1563
قاعدة البيانات: Springer Nature Journals
الوصف
تدمد:02683369
14765365
DOI:10.1038/s41409-022-01748-w